The latest closing stock price for Terns Pharmaceuticals as of September 18, 2024 is 10.21.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-445 today, roughly 0 times their original investment - a -13.68% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 11.7% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 3.26, which is 68.1% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 6.41.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-445 today, roughly 0 times their original investment - a -13.68% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 11.7% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 3.26, which is 68.1% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 6.41.